Dr. Baudouin's work focuses on the identification of molecular pathways and neuronal networks involved in the development of social skills and their breakdown in pathological conditions, in particular ASD or schizophrenia.
Dr. Jabaudon is Director of the Geneva University Neurocenter, Clinical neurologist and Professor at the Geneva University Hospital.
He is investigating interactions between genes and environment during normal and abnormal brain development with a focus on mechanisms controlling cortical development.
Dr. Lüscher's work has focused on studying the hypothesis that altered synaptic transmission evoked by addictive drugs causes adaptive behaviors. Dr. Lüscher’s expertise in circuit neuroscience has extended to ASD through the study of how SHANK3 insufficiency affects specific neural circuits. Dr. Lüscher is an advanced ERC grant holder.
Dr. Wang is Deputy Director for Clinical Research at the Simons Foundation, the leading non-profit funder of research on Autism Spectrum Disorder. He previously served at Autism Speaks, as Senior Vice President and Head of Medical Research, from 2013 to 2016. Dr. Wang's experience also spans pharma and biotech, having led Clinical Development for ASD and Fragile X syndrome as Vice President at Seaside Therapeutics between 2008 and 2013, and holding positions of increasing responsibility at Pfizer, from 2002-2008. Trained as a developmental-behavioral pediatrician, Dr. Wang has worked with hundreds of families affected by ASD and related genetic disorders. He has held leadership positions in the American Academy of Pediatrics, American Board of Pediatrics and the Society for Developmental-Behavioral Pediatrics.